CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12
BERKELEY HEIGHTS, N.J., July 28, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the second quarter ended June 30, 2021, after the market close on Thursday, August 12, 2021, and will host a corporate update conference call at 4:30pm Eastern Time.
Healthcare: The Patient The Doctor and The Bill
Keynote Presentation - Open to all Badge Holders
Presentation Details TBA